The Industrial Participant Program, part of the Wyss Diagnostics Accelerator, provides a hub for collaboration and guidance to move promising tech forward.
Sherlock Biosciences Licenses Ambient Temperature Amplification Tech From Wyss Institute
Sherlock plans to integrate the method with its CRISPR platform to develop instrument-free diagnostic assays for low-resource settings.
NanoMosaic Licenses Post-Operative Delirium Test From Mass General, Harvard Medical School
The test uses NanoMosiac's nanoneedle technology to diagnose patients with anesthesia-induced delirium and Alzheimer's disease.
The electrochemical test detects both the presence of SARS-CoV-2 RNA as well as virus antibodies in saliva.
3EO Health Licenses At-Home, Molecular Testing Technology from Wyss Institute
The company says the technology could provide access to PCR-grade infectious disease tests at antigen-level cost.
Feb 17, 2021